Before routine vaccines were developed in the 1900s, many children did not survive to adulthood and many adults did not reach old age. People succumbed in large numbers to diseases such as whooping ...

French drug company Sanofi announced it's discontinuing research and development for its next-generation mRNA flu vaccine. The company shared the news in an earnings document, saying it was ending the ...

Every year, flu vaccines are updated to match the flu viruses expected to circulate. For 2026, the vaccine focuses on several influenza strains that research predicts will be most prevalent. This ...

In February 2014, the World Health Organization (WHO) tried to predict which strains of influenza were going to pose the biggest threat in that year’s Northern Hemisphere flu season. It failed. On the ...

The COVID-19 response has exposed gaps in pandemic preparedness and revealed opportunities to enhance global vaccine development by leveraging novel technologies and streamlining research efforts. At ...

Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. While the media's attention has focused on unproven links between ...

India, June 23 -- The US Food and Drug Administration's (FDA) independent vaccine advisory committee has recommended approval of Moderna's influenza vaccine MFLUSIVA, an mRNA-based seasonal flu shot ...

Health Secretary Robert F. Kennedy Jr. has spent years campaigning against vaccines, but with the flu shot, he's suggested it's personal. Kennedy has linked his strained, raspy speech to the vaccine, ...

Influenza is a seasonal condition that causes coughing, sneezing, mild fever and aches in most cases. However, it can sometimes take a serious turn, leading to hospitalization, especially for young ...